Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks again Captain.
GLTU
And at least 5 overhere!
GLTU
Me too.
GLTU
Peter Davis reposted
UCLA Neurology
@UCLANeurology
The UCLA Brain Tumor Center is hosting the 24th Annual UCLA Brain Tumor Conference on Friday, May 10, and Saturday, May 11!
Join patients & healthcare professionals at this free conference to hear the latest news on brain tumors, resources, and more! http://uclahealth.org/braintumor
Peter Davis reposted
kristen shaughnessy
@kshaughnessy2
The CAT system is designed to protect against illegal trades. Ask yourself why some are fighting so hard against it while claiming to protect "retail investors" ?
"After 14 years of debate, the Securities and Exchange Commission is in the final stages of bringing a powerful new surveillance tool fully online. But Wall Street is seizing on the ideal political environment for a last-ditch attempt to kill it.
The Consolidated Audit Trail is a database, one of the largest ever created, that is set to revolutionize how the agency monitors trading activity and spots potential misconduct. ..."
https://bloomberg.com/news/articles/2024-05-02/citadel-securities-leads-suit-to-gut-sec-trading-surveillance
Gregory Zivic, MD
@metacollectiveG
$NWBO The Eden version of the automated dendritic cell manufacturing process will be worth at least $20 billion. It’s versatility in being able to create not just #DCVax but other DC based treatments is beyond anything seen in Biotech to date. I believe a C suite can handle 5-8
5:08 PM · May 3, 2024
·
655
Views
First see then believe ilovetech.
GLTU
Thank you Truthfan.
GLTU
Well done tryn2 !
GLTU
I was one of the lucky ones who was able to buy a mountain of shares at 14 and 15 cents in 2017.
GLTU
Nevercure.
I think they have gone insane at Pharmakon Advisors.
https://finance.yahoo.com/news/novocure-secures-400-million-multi-110100912.html
Spartex,
A while ago we had a person here on the board, basher,
whose nickname was Dr.Lowenstein.
I suspect he is now spewing his filth here under a different name.
GLTU
It is particularly noteworthy that a Dr. Lowenstein is mentioned at the beginning of the Article :):):)
GLTU
Thanks Captain.
GLTU
Captain,
It was Smokey if I'm not mistaken a few days ago.
According to him, it was most likely the exercise of the warrants that increased the outstanding number of shares.
I can't find his post about this at the moment.
GLTU
Together they form a large platform!
GLTU
Thanks Captain.
GLTU
We are on the cusp of recognition of a treatment for many (if not all) types of cancer that is unprecedented and on the verge of quickly becoming a cure. With "simply a vaccine". Not a toxic gang.
Can we compare it with other discoveries in the medical world?
Antibiotics maybe?
In any case, it will help many millions of people.
Eve!
And unfortunately there are longs here on the board who have waited years for this recognition and now want to flee?
And why? Because the price ends in the red almost every day?
They are being kicked around by a bunch of criminals who will most likely get their well-deserved reward in the foreseeable future: prosecution and striped suits. Creating pure frustration at longs.
All milestones required to exploit the product have been virtually delivered by Linda Powers, Linda Liau, Dr.Bosch and many others.
An incredible achievement to have repelled all attacks from various sides for almost 9 years (after the 'farewell' of Mr. Woodford) and to have found many solutions (to major problems) that none of us could have come up with.
Powers is brilliant!
How is it possible that after waiting 10 years there are people who cannot endure another few months, a few weeks or even shorter?
It seems that the criminals' tactics have already claimed some victims.
Pity.
Peter Davis
@peter_brit
#dcvax $nwbo #gbm
I looked again at the 'hit piece' and forced correction of the article by Ethan Chen, Alexander L Ling, David A Reardon, E Antonio Chiocca. As my post referenced below, there were in fact a number of other false claims made which were not addressed by these authors however, I found it of particular interest that not only was the 'hit piece' the 'editor's choice' but actually when you click on the correction there is something really interesting. It appears they grudgingly corrected just one of a number of flawed and incorrect statements but in sheer desperation to continue negativity towards DCVax results, on the same correction article they have a list of four 'Recommended' articles, three of which are 'hit pieces' against DCVax:-
Recommended:
First results on the DCVax phase III trial: raising more questions than providing answersWolfgang Wick et al., Neuro-Oncology, 2018
https://academic.oup.com/neuro-oncology/article/20/10/1283/5077256?itm_medium=sidebar&itm_source=trendmd-widget&itm_campaign=Neuro-Oncology&itm_content=Neuro-Oncology_0
Dendritic cell vaccine trials in gliomas: Untangling the linesKelly M Hotchkiss et al., Neuro-Oncology
https://pubmed.ncbi.nlm.nih.gov/37289203/
This obvious bias got me to question who was the Editor in question and it turns out to be Susan M Chang who is the editor-in-chief, her profile attached below is very telling. Couple this along with the fact that Matthias Preusser (an author of another DCVax hit piece) is executive editor, E Antonio Chiocca Associate editor(author of hit piece and forced to correct) also:
Martin J. van den Bent,John de Groot, David A. Reardon and Susan Short, who have all co-authored 'hit pieces' against DCVax are on the Editorial Board
Not only serious attempts to attack DCVax's results but a coordinated attack it seems all from one journal and assisted by the editor-in-chief. Not on of these Doctors found anything wrong with the original article ? 🤔
#dcvax #allsolidtumors $nwbo #gbm
— Peter Davis (@peter_brit) November 29, 2023
In a nutshell...
I asked Microsoft's AI to provide the following response to the article by Ethan Chen, Alexander L Ling, David A Reardon, E Antonio Chiocca
Thank you for your question. I have analysed and commented on the article by Chen…
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) April 12, 2024
Strategies to Improve Drug Delivery Across the Blood–Brain Barrier for Glioblastoma
Published: 05 April 2024
Hilarious.. In this recent article the authors grudgingly accept that "DCVax-L in recurrent and newly diagnosed GBM reported a survival benefit"but… pic.twitter.com/DAP4wYZeuI
I could be wrong, but I think we've discussed Advent costs in the past.
I thought the talk at the time was that Advent would of course get the production costs and on top of that another 15% of that amount as margin.
imo
Anyone?
GLTU
Captain,
I may be too gullible, but I certainly can't imagine LP would screw us over like that.
Not after everything we've been through with her.
IMO of course.
beartrap,
In my 45 years of trade fair experience, I have never heard of, let alone seen, something like this.
GLTU
Post
See new posts
Conversation
Peter Davis reposted
hoffmann6383
@hoffmann6383
🧑⚖️Harrington Discovery Update: Market Makers are slowly losing the battle to protect the identity of third parties involved in spoofing🧑⚖️
$NWBO $BOC
@CIBCCM
@VirtuFinancial
The Case: Harrington Global Opportunity Fund, Limited v. BofA Securities, Inc., 1:21-cv-00761, (S.D.N.Y.)
Plaintiff: Harrington Global Opportunity Fund, Limited
Defendant Market Makers: TD Securities (USA) LLC, TD Securities, Inc., SG Americas Securities, LLC, Merrill Lynch Canada Inc., CIBC World Markets Inc., and BofA Securities, Inc.
In federal court the parties are obligated to meet and confer regarding any discovery issues before bringing the matter to the Court’s attention. On April 17th the Plaintiff in the above case requested an extension of the fact discovery timeline (Docket Entry #214). The plaintiff explained that Defendant had not complied with discovery and summarized negotiations between the parties to resolve said discovery disputes. In this post I’ll quickly address some of those negotiations.
Docket Entry #214: https://courtlistener.com/docket/46947528/harrington-global-opportunity-fund-limited-v-bofa-securities-inc/
✅Plaintiff seeks communications regarding Defendants' algorithms
"Defendants also have failed to produce documents and communications concerning algorithms used by customers or Defendants in the trading at issue (the only partial exception is Merrill, which produced a small number of documents concerning trading algorithms recently, after resisting production for months)."
✅Plaintiff seeks communications between Defendants' customers and Defendants
"These open discovery issues—which have resulted in Defendants having produced virtually zero emails with customers or about customers concerning their trading behavior in Concordia—must be resolved well before depositions commence."
✅Market Makers other than the listed Defendants are involved in the alleged spoofing
"And even in doing so, CIBC confirmed on the same day that it is refusing to produce data reflecting approximately 21 million shares of Concordia executed through Virtu, a third-party broker, and transferred to CIBC during the Relevant Period."
✅Virtu and other non-defendant market makers have received, or are likely to receive, subpoena(s)
"In light of these developments, Harrington now must (1) confer with CIBC regarding the data that CIBC has refused to produce (among other open issues); (2) analyze the existing dataset to confirm it is in fact complete; (3) perform a millisecond matching analysis of the full dataset to identify orders for deanonymization pursuant to the Court’s March 18 and March 21 Orders; (4) meet and confer with CIBC on that issue as needed; (5) after receiving the deanonymized identities, evaluate any coordinated spoofing activity, including through third-party discovery; and (6) prepare for and take fact depositions." (emphasis added)
"Moreover, as the Court will recall, Merrill discovered only in January 2024—as a result of an admitted “screw up”—that the vast majority of customer trade and order data it had yet to produce was held by a third party.…and Harrington has issued a subpoena to the third party." (emphasis added)
✅Customers are likely to receive subpoena(s)
"But some of the most promising potential compromises the parties have discussed will require Harrington to first obtain and then review the complete trade and order data, obtain deanonymization of certain trading activity as ordered by the Court, and attempt to tailor document requests to customers and accounts believed to be involved in spoofing." (emphasis added)
7:35 PM · Apr 18, 2024
·
5,060
Views
Post
See new posts
Conversation
Peter Davis
@peter_brit
#dcvax $nwbo #gbm
Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination Francesco Pasqualetti © The Author(s) 2023 1,2,4✉ and Sofia Zanotti 3,4
Again we have failures to disclose conflict of interests by another Doctor who specialises in Radiology, criticizes DCVax results and yet declares "no conflict of Interests"
We know that multiple Doctors specializing in Radiology have come out to criticize DCVax as they see their jobs under threat, this does not give them the right however, not to abide by their Hippocratic oath and not to disclose the fact their earnings come from a treatment that DCVax technology could potentially replace.
s41416-023-02194-1.pdf (http://nature.com)
Radio-chemotherapy with Temozolomide in Elderly Patients with Glioblastoma. A Mono-institutional Experience | Anticancer Research (http://iiarjournals.org)
Thanks Captain.
GLTU
Thank you for this answer hyperopia.
I have to say that I already doubted whether it was intended for me.
I probably just reacted too quickly.
And, indeed, those doctors should be deeply ashamed.
Sorry for the confusion.
Best to you.
Totally agree Chiugray.
Unfortunately, I have experienced this several times on the American stock exchanges.
I have become wise through trial and error and most likely know what awaits me with this NWBO adventure: Lots of good and financial carefree.
Thank you for your response.
Best to you.
This article states: "Antonio Chiocca was being interviewed in a podcast where he (and the interviewer) continues to link DCVax to a "failed phase 3 trial"
What does this have to do with John Fortunato ( the interviewer)?
I don't understand your aggression.
GLTU
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174216659
We will therefore see the necessary 5 year OS figures in the 2nd half of 2029.
Tommy Bax 🇬🇧 🇹🇼
@TommyBaxendale
@EAChiocca
is definitely upholding his Hippocratic oath and having peers/ general public question his work.
Nothing to hide whatsoever… although I just found he blocked me because I reasonably questioned his paper last year.
Time for others to question him I think!
$NWBO
12:15 PM · Apr 10, 2024
·
1,942
Views
Kauri Capital
@KauriCapital
·
11h
Disclosure of Potential Conflicts of Interest
E.A. Chiocca has an ownership interest (including patents) and is a consultant/advisory board member of DNAtrix. S.D. Rabkin has an ownership interest (including patents) as coinventor on oncolytic HSV patents.
Peter Davis
@peter_brit
#dcvax $nwbo #gbm
Truly unbelievable....
Just as Neuro-oncology published the correction to the article attacking DCVax results with flawed and incorrect information whilst the four authors failed to disclose their conflict of Intersts, on March 8th It turns out one of those authors E Antonio Chiocca was being interviewed in a podcast where he (and the interviewer) continues to link DCVax to a "failed phase 3 trial"
He is obviously that desperate to project DCVax as a failed treatment regardless of the evidence to the contrary!
I have notified #nwbo
https://soc-neuro-onc.libsyn.com/website/immunotherapy-for-glioblastoma-lessons-learned
Thanks Captain.
GLTU
3 days already.
GLTU
I see that your meeting room, investorvillage, has disappeared from the internet.
Or deleted?
What bad luck for you and your friends, right?
Can't these people be pilloried by this or that person?
Now or later?
It's a shame!
GLTU
Post
See new posts
Conversation
Peter Davis
@peter_brit
·
1h
#dcvax $nwbo #gbm
First Published: 23 November 2023. it has taken nearly five months of likely screaming and kicking' and throwing their "teddy out of their cot" But the authors..
Ethan Chen, Alexander L Ling, David A Reardon, E Antonio Chiocca
all of who failed to disclose…
Show more
d_stock
@d_stock07734
·
1h
The paper needs further modifications to disclose the fact that Dr. David Reardon is working as SAB member of Immunomic Theraleutics.
Peter Davis
@peter_brit
#dcvax $nwbo #gbm
As you are aware and have pointed out previously the problem is much greater than just Reardon, I have posted on numerous occasions about failures to disclose conflict of interests by all these authors. The fact it took nearly five months for this correction without any apology speaks volumes.
Thanks Peter (pgsd) !
Peter Davis
@peter_brit
·
1h
#dcvax $nwbo #gbm
First Published: 23 November 2023. it has taken nearly five months of likely screaming and kicking' and throwing their "teddy out of their cot" But the authors..
Ethan Chen, Alexander L Ling, David A Reardon, E Antonio Chiocca
all of who failed to disclose…
https://academic.oup.com/neuro-oncology/article/26/4/779/7477448
Peter Davis
@peter_brit
·
21m
#dcvax $nwbo #gbm
Quote
Dr. Thomas Ichim
@exosome
·
15h
The $NWBO technology is so exciting because it can be plugged into so many other medical areas besides #oncology